<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chromosome 5 abnormalities, deletion of the long arm of chromosome 5 (del(5q)) or <z:mp ids='MP_0004026'>monosomy</z:mp> 5 (-5), arise in about 10% of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), either as the sole cytogenetic abnormality or as part of complicated karyotype, and has distinct clinical implications for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the prognostic factors of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with chromosome 5 abnormalities are not determined yet </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, 183 Japanese <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with chromosome 5 abnormalities were analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>Estimated incidence of del(5q) and <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q- syndrome</z:e> among <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients was 8.4 and 1.3%, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Significant shorter overall survival (OS) and <z:hpo ids='HP_0001909'>leukemia</z:hpo>-free survival (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e>) were observed in -5 patients than del(5q) patients </plain></SENT>
<SENT sid="5" pm="."><plain>Among del(5q) patients, addition of <z:mp ids='MP_0004026'>monosomy</z:mp> 7 or complex karyotype with more than three abnormalities were significantly related to shorter OS </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> of del(5q) patients was divided into two risk groups by international prognostic scoring system (IPSS): low/intermediate (Int)-1 and Int-2/high groups </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LFS</z:e> sorted by World Health Organization classification-based prognostic scoring system (WPSS) was also divided into two groups: very low/low/Int and high/very high, and WPSS was able to predict the outcome of del(5q) patients more clearly than IPSS </plain></SENT>
<SENT sid="8" pm="."><plain>Together with additional cytogenetic data, WPSS might be useful for clinical decision making in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with del(5q) </plain></SENT>
</text></document>